Dynamic, personalized treatment approach may improve outcomes in gastroesophageal cancers
E-Mail A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls. The final results were published online on Jan. 21 in Cancer Discovery, a journal of the American Association for Cancer Research. Advances in technology have made it possible for scientists and physicians to use information about the genetic makeup of a cancerous tumor to in...
Source: eurekalert.org